Skip to main content
VIYASH SCIENTIFIC LIMITED logo

VIYASH SCIENTIFIC LIMITED — Investor Relations & Filings

Ticker · VIYASH ISIN · INE807F01027 LEI · 335800SXM7D3VSHF2X07 BSE.NS Manufacturing
Open in API
Filings indexed 1,420 across all filing types
Latest filing 2026-03-31 Board/Management Inform…
Country IN India
Listing BSE.NS VIYASH

About VIYASH SCIENTIFIC LIMITED

https://www.viyash.com

Viyash Scientific Limited is an integrated pharmaceutical platform specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs), advanced intermediates, and finished dosage forms. The organization operates a network of manufacturing facilities supported by robust research and development capabilities, focusing on complex chemistry and niche therapeutic segments. Its core business activities encompass the entire pharmaceutical value chain, from process development and scale-up to commercial-scale production. The company provides integrated solutions to global partners, leveraging its technical expertise in chemical synthesis and commitment to international quality standards. By maintaining a focus on operational excellence and innovation, the company serves as a strategic partner in the global healthcare supply chain, delivering high-quality medicinal components and formulations.

Recent filings

Filing Released Lang Actions
Updates
Board/Management Information Classification · 100% confidence The document is a letter addressed to stock exchanges clarifying a previous intimation about the resignation of two Non-Executive Directors. It references Regulation 30 of the SEBI Listing Regulations, which pertains to disclosure of events or information by listed entities. The content is about management changes, specifically resignations of board members, and is a formal announcement to the exchanges. The document length is short (2001 characters) and does not contain financial data or detailed reports. Therefore, it fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2026-03-31 English
Resignation of Directors
Board/Management Information Classification · 86% confidence The document is an official intimation under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements. It notifies the stock exchanges of the resignations of two non-executive directors, provides annexures with detailed information and resignation letters, and is clearly announcing changes in the company's board of directors. This matches the Board/Management Information category (MANG).
2026-03-30 English
Resignation
Board/Management Information Classification · 92% confidence The document is a formal intimation under Regulation 30 of the SEBI LODR, announcing the resignation of two Non-Executive Directors and providing required annexures. This constitutes a board/management change announcement rather than a financial report, vote result, or other category. Therefore it fits “Board/Management Information” (MANG).
2026-03-30 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notice from Viyash Scientific Limited informing stock exchanges about the closure of the trading window for insiders ahead of the announcement of audited financial results for the quarter and year ending March 31, 2026. It references the upcoming financial results but does not contain any financial data or the results themselves. The document is short (2140 characters) and serves as an announcement related to compliance with insider trading regulations rather than a financial report or detailed filing. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for such compliance and regulatory announcements that do not fit other specific categories.
2026-03-30 English
Closure of Trading Window
Regulatory Filings Classification · 95% confidence The document is a notice from Viyash Scientific Limited informing about the closure of the trading window for insiders ahead of the declaration of audited financial results for the quarter and year ending March 31, 2026. It references the upcoming financial results but does not contain any financial data or the results themselves. The document is short (2140 characters) and serves as an announcement related to compliance with insider trading regulations rather than a financial report. Therefore, it is not an Annual Report, Earnings Release, or Interim Report. It is also not a certification or a voting result announcement. The document is best classified as a Regulatory Filing (RNS) because it is a compliance-related announcement that does not fit into other specific categories.
2026-03-30 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is an official notice to stock exchanges providing the voting results of a postal ballot along with the scrutinizer’s report, under SEBI Listing Regulations. It contains detailed vote counts for resolutions passed by shareholders. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-03-13 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.